<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1657-4702</journal-id>
<journal-title><![CDATA[Revista Latinoamericana de Bioética]]></journal-title>
<abbrev-journal-title><![CDATA[rev.latinoam.bioet.]]></abbrev-journal-title>
<issn>1657-4702</issn>
<publisher>
<publisher-name><![CDATA[Universidad Militar Nueva Granada]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1657-47022021000200025</article-id>
<article-id pub-id-type="doi">10.18359/rlbi.5076</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Propiedad intelectual, patentes y salud: una mirada desde la Bioética]]></article-title>
<article-title xml:lang="en"><![CDATA[Intellectual Property, Patents, and Health: a Look from Bioethics]]></article-title>
<article-title xml:lang="pt"><![CDATA[Propriedade intelectual, patentes e saúde: uma perspectiva a partir da Bioética]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García Uribe]]></surname>
<given-names><![CDATA[John Camilo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Corporación Universitaria Remington  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>21</volume>
<numero>2</numero>
<fpage>25</fpage>
<lpage>40</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S1657-47022021000200025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S1657-47022021000200025&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S1657-47022021000200025&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Artículo de carácter reflexivo y argumentativo que busca confrontar referentes conceptuales desde la Bioética y el derecho para dar solución a estos interrogantes: ¿son los derechos de propiedad intelectual la antítesis de otros derechos? ¿Existe un conflicto de principios bioéticos en dicha tensión? ¿Cómo abordar desde la Bioética este choque de miradas? ¿Es necesario un cambio de paradigma para transformar el individualismo imperante de la contemporaneidad y evitar los daños de una guerra de rapiñas que se enmascara detrás de un eufemismo de la competencia de mercados y la propiedad intelectual? Entre argumentos, cuestionamientos y disensos se busca un abordaje a estos dilemas con un enfoque bioético. Se deja sobre la mesa la cooperación con una base de empatía y compasión para desviarse del camino del individualismo pernicioso y la voracidad subsecuente del dinero y el poder. Por ello, la Bioética como puente hacia al futuro es la disciplina llamada manifestar dicha cooperación, no solo en los ámbitos disciplinarios, sino entre los diferentes actores sociales, entre los protagonistas de esta obra, para que su final no sea trágico, sino esperanzador y saludable.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary: This is a reflexive and argumentative article which intention is to confront conceptual references from bioethics and the right to solve the following questions: are intellectual property rights the antithesis of other rights? Is there a conflict of bioethical principles in this discussion? How to address from Bioethics this difference in point of views? Is a paradigm shift necessary to transform the prevailing individualism of contemporaneity and avoid the damages of a war of plunder masked behind a euphemism of market competition and intellectual property? Between arguments, questions and dissents, an approach to these dilemmas is sought with a bioethical approach. Cooperation is on the table based on empathy and compassion to divert it from the path of pernicious individualism and the subsequent voracity of money and power. Therefore bioethics, as a bridge to the future is the discipline called to manifest this cooperation, not only in disciplinary areas, but between the different social stakeholders, among those main players of this work, so that its end is not tragic, but hopeful and healthy.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: Artigo reflexivo e argumentativo que busca confrontar referências conceituais da Bioética e do direito para resolver as seguintes questões: os direitos de propriedade intelectual são a antítese de outros direitos? Existe um conflito de princípios bioéticos nessa tensão? Como abordar este choque de perspectivas a partir da Bioética? É necessária uma mudança de paradigma para transformar o individualismo predominante da contemporaneidade e evitar os danos de uma briga que se mantém mascarada por trás de um eufemismo de concorrência de mercado e propriedade intelectual? Entre argumentos, perguntas e dissensos, busca-se uma abordagem desses dilemas com uma abordagem Bioética. A cooperação é deixada sobre a mesa com uma base de empatia e compaixão para se desviar do caminho do individualismo pernicioso e da subsequente voracidade do dinheiro e do poder. Portanto, a Bioética, como ponte para o futuro, é a disciplina convocada a manifestar tal cooperação, não apenas nos campos disciplinares, mas entre os diferentes atores sociais, entre os protagonistas deste trabalho, para que seu fim não seja trágico, mas esperançoso e saudável.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[propiedad intelectual]]></kwd>
<kwd lng="es"><![CDATA[patentes]]></kwd>
<kwd lng="es"><![CDATA[discusiones Bioéticas]]></kwd>
<kwd lng="es"><![CDATA[valor de la vida]]></kwd>
<kwd lng="es"><![CDATA[capitalismo]]></kwd>
<kwd lng="es"><![CDATA[acceso a la atención en salud]]></kwd>
<kwd lng="en"><![CDATA[intellectual property]]></kwd>
<kwd lng="en"><![CDATA[patents]]></kwd>
<kwd lng="en"><![CDATA[bioethical discussions]]></kwd>
<kwd lng="en"><![CDATA[value of life]]></kwd>
<kwd lng="en"><![CDATA[capitalism]]></kwd>
<kwd lng="pt"><![CDATA[propriedade intelectual]]></kwd>
<kwd lng="pt"><![CDATA[patentes]]></kwd>
<kwd lng="pt"><![CDATA[discussões Bioéticas]]></kwd>
<kwd lng="pt"><![CDATA[valor da vida]]></kwd>
<kwd lng="pt"><![CDATA[capitalismo]]></kwd>
<kwd lng="pt"><![CDATA[acesso a serviços de saúde]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Organización Mundial de Propiedad Intelectual</collab>
<source><![CDATA[Principios básicos de la propiedad industrial]]></source>
<year>2016</year>
<edition>2</edition>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Propiedad Intelectual]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gehrke]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is Gene Editing Patentable?]]></article-title>
<source><![CDATA[AMA J Ethics]]></source>
<year>2019</year>
<numero>12</numero>
<issue>12</issue>
<page-range>E1049-55</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dreyfuss]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Pila]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[The Oxford Handbook of Intellectual Property Law]]></source>
<year>2018</year>
<edition>1</edition>
<publisher-loc><![CDATA[Oxford ]]></publisher-loc>
<publisher-name><![CDATA[Oxford University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kinsella]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Contra La Propiedad Intelectual]]></source>
<year>2001</year>
<publisher-loc><![CDATA[Auburn ]]></publisher-loc>
<publisher-name><![CDATA[Ludwig von Mises Institute]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schulman]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Informational property: Logorights]]></article-title>
<source><![CDATA[J Soc Biol Struc]]></source>
<year>1990</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>93-117</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los demás]]></article-title>
<source><![CDATA[Un rincón del alma]]></source>
<year>2010</year>
<publisher-name><![CDATA[Amazon Music]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heidegger]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Ser y tiempo]]></source>
<year>2018</year>
<edition>3</edition>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Trotta]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ginsburg]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[From Hypatia to Victor Hugo to Larry and Sergey: 'All the world's knowledge' and universal authors' rights]]></article-title>
<source><![CDATA[J Br Acad]]></source>
<year>2013</year>
<numero>1</numero>
<issue>1</issue>
<page-range>71-94</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hanahan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Palmiter]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer]]></article-title>
<source><![CDATA[Genes Dev]]></source>
<year>2007</year>
<volume>21</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>2258-70</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrier]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cabining Intellectual Property through a Property Paradigm]]></article-title>
<source><![CDATA[Duke Law J]]></source>
<year>2004</year>
<volume>54</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-145</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palmer]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Are Patents and Copyrights Morally Justified? The Philosophy of Property Rights and Ideal Objects]]></article-title>
<source><![CDATA[Harv J Law Pub Pol]]></source>
<year>1990</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>817-65</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spooner]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[The Law of Intellectual Property: or An Essay on the Right of Authors and Inventors to a Perpetual Property in Their Ideas]]></source>
<year>1855</year>
<publisher-loc><![CDATA[Boston ]]></publisher-loc>
<publisher-name><![CDATA[Bela Marsh]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Locke]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Ensayo Sobre el gobierno civil]]></source>
<year>2003</year>
<publisher-loc><![CDATA[Ciudad de México ]]></publisher-loc>
<publisher-name><![CDATA[Porrúa]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Locke]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Segundo tratado sobre el gobierno civil]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Bernal ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional de Quilmes]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miyagusuku]]></surname>
<given-names><![CDATA[JLT]]></given-names>
</name>
</person-group>
<source><![CDATA[El derecho de propiedad en John Locke]]></source>
<year>1997</year>
<publisher-loc><![CDATA[Lima ]]></publisher-loc>
<publisher-name><![CDATA[Pontificia Universidad Católica del Perú]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fazio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conceptual Foundations of Intellectual Property]]></article-title>
<source><![CDATA[Ideas Val]]></source>
<year>2019</year>
<volume>68</volume>
<numero>170</numero>
<issue>170</issue>
<page-range>121-45</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Udi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Locke, propiedad privada y redistribución]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Bernal ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional de Quilmes]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cándano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Propiedad intelectual en Cuba. Una mirada crítica a su reconocimiento constitucional]]></article-title>
<source><![CDATA[Rev Chil Der Tec]]></source>
<year>2019</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>133-65</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beltrán]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La crítica de Nozick a la teoría lockeana sobre la adquisición de la propiedad]]></article-title>
<source><![CDATA[Cuad Fac Der]]></source>
<year>1992</year>
<numero>18</numero>
<issue>18</issue>
<page-range>117-26</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nozick]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Anarquía, Estado y utopía]]></source>
<year>1988</year>
<edition>1</edition>
<publisher-loc><![CDATA[México, Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Fondo de Cultura Económica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mendoza]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[En la adolescencia de la Bioética]]></article-title>
<source><![CDATA[Etices]]></source>
<year>2016</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>12</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardona]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ánjel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[El Cuidado de la casa común. Una conversación a dos voces entra la enciclica Laudato sí' y Genesis 1-4. Xave]]></source>
<year>2019</year>
<volume>69</volume>
<numero>188</numero>
<issue>188</issue>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thierer]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Crews]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
</person-group>
<source><![CDATA[Cato Institute, editores. Copy fights: the future of intellectual property in the information age]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Washington, D. C. ]]></publisher-loc>
<publisher-name><![CDATA[Cato Institute]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spinella]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Patentar la vida y enajenar el futuro. Un análisis crítico de las patentes de invención sobre el genoma humano]]></source>
<year>2015</year>
<publisher-loc><![CDATA[La Plata ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional de la Plata]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Islam]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kaplan]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
<name>
<surname><![CDATA[Trachtenberg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Thrasher]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gallagher]]></surname>
<given-names><![CDATA[KP]]></given-names>
</name>
<name>
<surname><![CDATA[Wirtz]]></surname>
<given-names><![CDATA[VJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review]]></article-title>
<source><![CDATA[Glob Health]]></source>
<year>2019</year>
<volume>15</volume>
<numero>88</numero>
<issue>88</issue>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ledezma Morales]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Amariles]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas Peláez]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi Buenaventura]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estrategias para promover el acceso a medicamentos de interés en salud pública: revisión estructurada de la literatura]]></article-title>
<source><![CDATA[Rev Fac Nac Salud Púb]]></source>
<year>2020</year>
<volume>38</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-14</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Contreras]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El aparato teórico en la estructura tradicional del sistema de propiedad intelectual]]></article-title>
<source><![CDATA[Vniversitas]]></source>
<year>2017</year>
<volume>66</volume>
<numero>135</numero>
<issue>135</issue>
<page-range>99-130</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Segre]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Iwamura]]></surname>
<given-names><![CDATA[ESM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioethics, intellectual property and genomics]]></article-title>
<source><![CDATA[Rev Hosp Clin Fac Med Sao Paulo]]></source>
<year>2001</year>
<volume>56</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>97-102</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fenwarth]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las patentes farmacéuticas como una herramienta para la garantía del derecho al acceso de medicamentos de calidad en Colombia]]></article-title>
<source><![CDATA[Rev Der Com Nuev Tecnol]]></source>
<year>2016</year>
<numero>16</numero>
<issue>16</issue>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Plant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Economic Theory Concerning Patents for Inventions]]></article-title>
<source><![CDATA[Economica]]></source>
<year>1934</year>
<volume>1</volume>
<numero>30</numero>
<issue>30</issue>
<page-range>30-51</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goldacre]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[Mala farma: Cómo las empresas farmacéuticas engañan a los médicos y perjudican a los pacientes]]></source>
<year>2013</year>
<edition>1</edition>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Ediciones Paidós]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ugalde]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Homedes]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicamentos para lucrar. La transformación de la industria farmacéutica]]></article-title>
<source><![CDATA[Salud Colect]]></source>
<year>2009</year>
<volume>5</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>305</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Packer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mercado]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Haridat]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioelectronic Medicine-Ethical Concerns]]></article-title>
<source><![CDATA[Cold Spring Harb Perspect Med]]></source>
<year></year>
<volume>9</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Durand]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Milberg]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intellectual Monopoly in Global Value Chains]]></article-title>
<source><![CDATA[Rev Int Polit Econ]]></source>
<year>2020</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>404-29</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aranda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rosasco]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La farmacia de los medicamentos genéricos]]></article-title>
<source><![CDATA[Rev Colomb Cienc Quím Farm]]></source>
<year>2019</year>
<volume>48</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>357-71</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evidence Regarding Research and Development Investments in Innovative and Non-Innovative Medicines]]></article-title>
<source><![CDATA[Love J]]></source>
<year>2003</year>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Light]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Warburton]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Setting the record straight in the reply by DiMasi, Hansen and Grabowski]]></article-title>
<source><![CDATA[J Health Econ]]></source>
<year>2005</year>
<volume>24</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>1045-8</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="">
<collab>Families USA Foundation</collab>
<source><![CDATA[Profiting from Pain: Where Prescription Drug Dollars Go]]></source>
<year>2002</year>
</nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johnston]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wasunna]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patents, Biomedical Research, and Treatments: Examining Concerns, Canvassing Solutions]]></article-title>
<source><![CDATA[Hastings Cent Rep]]></source>
<year>2007</year>
<volume>37</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-36</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Washington]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Deadly Monopolies: The Shocking Corporate Takeover of Life Itself-And the Consequences for Your Health and Our Medical Future]]></source>
<year>2011</year>
<edition>1</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Double Day]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berlinguer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Bioética cotidiana]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Ciudad de México ]]></publisher-loc>
<publisher-name><![CDATA[Siglo XXI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mojica]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Idárraga]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pascuas]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioética y la brecha 10/90: fallos, desafíos y oportunidades]]></article-title>
<source><![CDATA[The New Courr Unesco]]></source>
<year>2014</year>
<volume>2</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>81-93</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gleeson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Lexchin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Labonté]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Townsend]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Gagnon]]></surname>
<given-names><![CDATA[M-A]]></given-names>
</name>
<name>
<surname><![CDATA[Kohler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts]]></article-title>
<source><![CDATA[Glob Health]]></source>
<year>2019</year>
<volume>15</volume>
<numero>78</numero>
<issue>78</issue>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shadlen]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
<name>
<surname><![CDATA[Sampat]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
<name>
<surname><![CDATA[Kapczynski]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patents, trade and medicines: past, present and future]]></article-title>
<source><![CDATA[Rev Int Polit Econ]]></source>
<year>2020</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>75-97</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA['t Hoen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Protect against market exclusivity in the fight against COVID-19]]></article-title>
<source><![CDATA[Nat Med]]></source>
<year>2020</year>
<volume>26</volume>
<numero>813</numero>
<issue>813</issue>
</nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Crowell]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A crisis in us drug pricing: Consequences for patients with neuromuscular diseases, physicians and society, part 1]]></article-title>
<source><![CDATA[Muscle Nerve]]></source>
<year>2020</year>
<volume>62</volume>
<page-range>567-72</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[RC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A brief history of AIDS]]></article-title>
<source><![CDATA[bmj]]></source>
<year>2006</year>
<page-range>333</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stigliz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jayadev]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Prabhala]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[¿Cómo funcionarán las patentes en una eventual vacuna contra el COVID-19?]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="book">
<source><![CDATA[Explicación de la Declaración de Doha relativa a los ADPic]]></source>
<year>2020</year>
<publisher-name><![CDATA[Organización Mundial del Comercio]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barton]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[trips And The Global Pharmaceutical Market]]></article-title>
<source><![CDATA[Health Aff]]></source>
<year>2004</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>146-54</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>51</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kottow]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bioética: una disciplina en riesgo]]></article-title>
<source><![CDATA[Rev Redbioét/Unesco]]></source>
<year>2010</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>159-73</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>52</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Byung-Chul]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[La Sociedad del cansancio]]></source>
<year>2012</year>
<edition>2</edition>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Herder]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B53">
<label>53</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ordine]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[La utilidad de lo inútil]]></source>
<year>2013</year>
<edition>3</edition>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Acantilado]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B54">
<label>54</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levinas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Totalidad e infinito]]></source>
<year>2012</year>
<edition>1</edition>
<publisher-loc><![CDATA[Salamanca ]]></publisher-loc>
<publisher-name><![CDATA[Ediciones Sígueme]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B55">
<label>55</label><nlm-citation citation-type="journal">
<collab>TED</collab>
<article-title xml:lang=""><![CDATA[Profit's not always the point]]></article-title>
<source><![CDATA[Manwani H]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B56">
<label>56</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harari]]></surname>
<given-names><![CDATA[YN]]></given-names>
</name>
</person-group>
<source><![CDATA[Sapiens. De animales a dioses]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Debate]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
